Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS
Selina M. Luger(Hospital of the University of Pennsylvania), Olle Ringdén(Karolinska Institutet), M-J Zhang(Medical College of Wisconsin), Waleska S. Pérez(Medical College of Wisconsin), Michael R. Bishop(National Institutes of Health), Martin Bornhäuser(Technische Universität Dresden), Christopher Bredeson(Froedtert Hospital), Mitchell S. Cairo(Morgan Stanley (United States)), Edward A. Copelan(Cleveland Clinic), Robert Peter Gale(Bristol-Myers Squibb (Switzerland)), Sergio Giralt(The University of Texas MD Anderson Cancer Center), Zafer Gülbaş(Gazi University), Vikas Gupta, Gregory A. Hale(Johns Hopkins University), Hillard M. Lazarus(Case Western Reserve University), Victor Lewis(Alberta Children's Hospital), Michael Lill(Cedars-Sinai Medical Center), Phillip McCarthy(Roswell Park Comprehensive Cancer Center), Daniel Weisdorf(Fairview Health Services), Michael A. Pulsipher(University of Utah)
Cited by 275Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis